Close Menu

NEW YORK (GenomeWeb) – Danaher today reported a 7 percent year-over-year increase in its third quarter revenues with its diagnostic revenues up 3 percent. 

For the three months ended Sept. 28, 2018, the Washington-based conglomerate tallied $4.85 billion in total revenues, up from $4.53 billion in Q3 2017. It beat the consensus Wall Street estimate of $4.80 billion. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

In Science this week: almond reference genome, and more.